20.500.12556/DiRROS-27242 European Code Against Cancer, 5th edition cancer-causing infections and related interventions The main infections that cause cancer in the European Union (EU) are Helicobacter pylori (H. pylori), human papillomavirus (HPV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Altogether, in 2022, these infections accounted for ~ 5% of all cancers in the EU, mainly of the stomach, cervix uteri and liver. The largest burden of infection-caused cancers was found in the south of the EU and near the eastern border. Substantial progress in the efficacy of interventions against these infections has been made since the release of the 4th edition of the European Code Against Cancer in 2015. Cancers due to infections can increasingly be prevented by prophylactic vaccines (HPV and HBV) and/or prompt diagnosis and treatment that can either cure (HCV and H. pylori) or slow down the infection (HBV and HIV), thus substantially reducing disease risk. Tools to tackle carcinogenic infections are also increasingly accessible and affordable in the EU, but their implementation is slow. Public awareness, political will and cost-effective protocols are necessary to establish large programmes of vaccination or testing and treatment. Progress monitoring, as well as avoiding disinformation and stigma, is crucial to ensure that advances in medical progress are fully leveraged. The recently published 5th edition of the European Code Against Cancer therefore recommends: (1) vaccinate girls and boys against HBV and HPV at the age recommended in your country; (2) take part in testing and treatment for HBV and HCV, HIV and H. pylori, as recommended in your country. Helicobacter pylori HBV HIV European Code Against Cancer cancer hepatitis B virus hepatitis C virus human immunodeficiency virus human papillomavirus true false true Angleški jezik Ni določen Neznano 2026-01-30 09:56:10 2026-01-30 09:56:13 2026-02-02 03:54:20 0000-00-00 00:00:00 2026 0 0 Nasl. z nasl. zaslona; Opis vira z dne 30. 1. 2026; str. 96-116 issue 1 Vol. 20 2026 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 0000-00-00 616.9 1878-0261 10.1002/1878-0261.70172 266758403 RAZ_Alberts_Catharina_Johanna_2026.pdf RAZ_Alberts_Catharina_Johanna_2026.pdf 1 E32811D332ABD5B58B90186E8AF40CA6 47a2d6cf681a04f395ccf4a06d00b516693287d640ee65eacb38eb9446bfed95 c2ef072a-fdb9-11f0-a15d-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=39731 https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70172 0 d07a891e-fdb9-11f0-a15d-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=39732 Univerzitetni klinični center Ljubljana 0 0 0